FDA inspection
WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd: FDA inspection ending Feb 2, 2024
FDA inspection 1256403 · Voluntary Action Indicated (VAI) · Suzhou
Key facts
| Inspection ID | 1256403 |
|---|---|
| Firm | WuXi Biologics Biosafety Testing (Suzhou) Co., Ltd |
| FEI number | 3015655844 |
| Address | Xinzhiyuan Building B, 1336 Wuzhong Avenue; Yuexizhen Wuzhong |
| City | Suzhou |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Feb 2, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data